An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope

Anthony Barnett, M Dreyer, P Lange, M Serdarevic-Pehar

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2333-2334
Number of pages2
JournalDiabetes Care
Volume29
Issue number10
DOIs
Publication statusPublished - 1 Oct 2006

Cite this